Paris (France), March 07, 2014 – IMSTAR is pleased to announce the recent collaboration with Japan Tobacco Inc. (JT) following the set-up of its Pathfinder™ Screentox Auto Micronucleus Image Cytometer System for in vitro/in vivo genetic toxicology studies at JT’s Research Center near Tokyo.
Japan Tobacco Inc. (JT) will apply Pathfinder™ Screentox technology for automated scoring of micronucleus test in different cell types. The use of this capability will add value by enhancing test accuracy and reliability. In addition, the versatility of this system will lay the foundation for the potential development of a new technical framework in the field of genetic toxicology studies applied to the tobacco industry.
“We are very happy about our new collaboration with Japan Tobacco Inc. It is our understanding that JT looked at several alternatives and chose IMSTAR for its long-standing, recognised expertise”, said Françoise Soussaline, IMSTAR’s President and CEO. “We have been at the forefront of the development of in vitro toxicology tests for years, not only in terms of their automation but also in terms of their scientific basis and standardization. Adding JT to our list of customers validates further is a further validation of our approach and our products”.